RSV Infection Prophylaxis Guidelines

Palivizumab (Synagis®)

In August 2007, the utilization management of palivizumab was transferred to the IWK Health Centre. For information regarding the guidelines for the use of this product and the request approval process, please go to the palivizumab section of the IWK Health Centre's website or contact:

Karen Chestney, RN
Provincial Palivizumab Monitoring Nurse
IWK Health Centre
470-2723

Date Revised: 
November, 2015